ZOVILOVIR 250 mg Lyophilized Powder for Solution for I.V. Infusion

It is indicated for the parenteral treatment of complicated skin and soft-tissue infections, bone and joint infections, hospital- or community-acquired pneumonia, complicated urinary tract infections, infective endocarditis, peritonitis associated with continuous ambulatory peritoneal dialysis, and bacteremia associated with these infections in adults and children from birth. It is also used as an alternative oral treatment for diarrhea and colitis caused by Clostridium difficile infection.

It is used in all age groups for the treatment of complicated skin and soft-tissue infections, bone and joint infections, community-acquired pneumonia, hospital-acquired pneumonia—including ventilator-associated pneumonia—and infective endocarditis; for perioperative antibacterial prophylaxis in patients at high risk of bacterial endocarditis; and, when administered orally, for the treatment of Clostridium difficile infections.

It is used in all age groups for the treatment of complicated skin and soft-tissue infections, bone and joint infections, community-acquired pneumonia, hospital-acquired pneumonia—including ventilator-associated pneumonia—and infective endocarditis; for perioperative antibacterial prophylaxis in patients at high risk of bacterial endocarditis; and, when administered orally, for the treatment of Clostridium difficile infections.

It is used for the treatment of serious respiratory tract, urinary tract, and genital tract infections caused by microorganisms susceptible to cefotaxime; septicemia, bacteremia, endocarditis, and intra-abdominal infections, including peritonitis; meningitis and other central nervous system infections; and infections of the skin and soft tissues, bones, and joints. It is also used for prophylaxis in gastrointestinal, genitourinary, obstetric, and gynecological surgery.